About
Dedicated, high-performing business leader with track record for business…
Articles by Mary
-
ICER - What do we think about ICER seeking input around low-value interventions in MS?
ICER - What do we think about ICER seeking input around low-value interventions in MS?
By Mary Fletcher-Louis
-
Three imperatives for the UK's pharma strategy
Three imperatives for the UK's pharma strategy
By Mary Fletcher-Louis
Activity
-
Updates to the AMNOG process in Germany have just been published in a GBA resolution. Amendments to Chapter 5 of the GBA’s Rules of Procedure address…
Updates to the AMNOG process in Germany have just been published in a GBA resolution. Amendments to Chapter 5 of the GBA’s Rules of Procedure address…
Liked by Mary Fletcher-Louis
-
Brilliant! “The master in the art of living makes little distinction between his work and his play, his labor and his leisure, his mind and his…
Brilliant! “The master in the art of living makes little distinction between his work and his play, his labor and his leisure, his mind and his…
Liked by Mary Fletcher-Louis
Experience & Education
Publications
-
U.S. PAYER EXPECTATIONS FOR REIMBURSEMENT OF BIOSIMILARS
Ispor
Other authors
Languages
-
English
Native or bilingual proficiency
-
French
Professional working proficiency
Recommendations received
2 people have recommended Mary
Join now to viewMore activity by Mary
-
Visited another Corner of the Müller UK & Ireland universe today 🐄🥛 Whether you call these kinds of conversations tricky, courageous…
Visited another Corner of the Müller UK & Ireland universe today 🐄🥛 Whether you call these kinds of conversations tricky, courageous…
Liked by Mary Fletcher-Louis
-
Trinity Life Sciences is excited to announce the return of the Next-Generation Launch Forum. Our one-day educational and networking event takes place…
Trinity Life Sciences is excited to announce the return of the Next-Generation Launch Forum. Our one-day educational and networking event takes place…
Liked by Mary Fletcher-Louis
-
I’ve been leaning into the phrase “move the needle” lately. It is what all our clients want to do when it comes to a drug launch – we want it to have…
I’ve been leaning into the phrase “move the needle” lately. It is what all our clients want to do when it comes to a drug launch – we want it to have…
Liked by Mary Fletcher-Louis
-
Clinical Trial Diversity is a strong driver of real-world decision uncertainty - without fundamental incorporation of a range of sociodemographic…
Clinical Trial Diversity is a strong driver of real-world decision uncertainty - without fundamental incorporation of a range of sociodemographic…
Liked by Mary Fletcher-Louis
-
Rolling reviews to speed up access to new medicines will be expanded by Canada's Drug Agency (CDA), formerly known as CADTH. This process allows drug…
Rolling reviews to speed up access to new medicines will be expanded by Canada's Drug Agency (CDA), formerly known as CADTH. This process allows drug…
Liked by Mary Fletcher-Louis
-
Our NICE International team helps countries improve their nation’s health and wellbeing by sharing best practice and expertise from NICE. Discover…
Our NICE International team helps countries improve their nation’s health and wellbeing by sharing best practice and expertise from NICE. Discover…
Liked by Mary Fletcher-Louis
-
Quick heads up to my network we will soon be formally announcing more hiring at Interactive Workshops for mid weight and senior L&D consultants who…
Quick heads up to my network we will soon be formally announcing more hiring at Interactive Workshops for mid weight and senior L&D consultants who…
Liked by Mary Fletcher-Louis
-
After 3 years of leading a fantastic team in the Novo Nordisk US affiliate focused on our Future Business Strategy, I’m happy to share that I am…
After 3 years of leading a fantastic team in the Novo Nordisk US affiliate focused on our Future Business Strategy, I’m happy to share that I am…
Liked by Mary Fletcher-Louis
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More